Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK
McKenna JK, Florell SR, Goldman GD, Bowen GM
Throughout the treatment, our team ensures your comfort and provides both pre-care and after-care support to enhance your overall experience
Semaglutide for weight loss is a prescription medication, which means it must be prescribed to you in order to purchase it online
Aspiration is not recommended for routine subcutaneous injections
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users